Currency in BRL
| Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 4 | 4 | 7 | 7 |
| Avg. Estimate | 0.86 | 0.87 | 3.15 | 3.58 |
| Low estimate | 0.7 | 0.78 | 2.22 | 2.62 |
| High estimate | 1.01 | 0.94 | 3.94 | 4.27 |
| Year ago EPS | 0.75 | 0.67 | 2.51 | 3.15 |
| Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 4 | 4 | 9 | 9 |
| Avg. Estimate | 1.75B | 1.86B | 6.86B | 7.29B |
| Low estimate | 1.69B | 1.84B | 6.18B | 6.32B |
| High estimate | 1.81B | 1.9B | 7.31B | 7.79B |
| Year ago sales | 1.63B | 1.63B | 6.25B | 6.86B |
| Sales growth (year/est) | 7.20% | 14.40% | 9.60% | 6.40% |
| Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
|---|
| Est. EPS | 0.54 | 0.62 | 0.69 | 0.78 |
| Actual EPS | 0.75 | 0.67 | 0.65 | 0.71 |
| Difference | 0.21 | 0.05 | -0.04 | -0.07 |
| Surprise % | 38.90% | 8.10% | -5.80% | -9.00% |
| EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0.86 | 0.87 | 3.15 | 3.58 |
| 7 days ago | 0.86 | 0.87 | 3.15 | 3.58 |
| 30 days ago | 0.84 | 0.83 | 3.07 | 3.62 |
| 60 days ago | 0.82 | 0.81 | 2.98 | 3.64 |
| 90 days ago | 0.78 | 0.88 | 2.93 | 3.64 |
| EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | 2 | 1 | 2 | 1 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | CYRE3.SA | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | 14.70% | N/A | N/A | N/A |
| Next qtr. | 29.90% | N/A | N/A | N/A |
| Current year | 25.50% | N/A | N/A | N/A |
| Next year | 13.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | 7.42% | N/A | N/A | N/A |
| Past 5 years (per annum) | 25.76% | N/A | N/A | N/A |
